Literature DB >> 7926038

Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells.

Y Wang1, C J Jones, J Dang, X Liang, J E Olsen, W F Doe.   

Abstract

The modulation of urokinase plasminogen activator receptor (uPAR) gene expression by tumor necrosis factor alpha (TNF alpha), phorbol ester (PMA) and amiloride was studied in three colon cancer cell lines. uPAR mRNA and protein were induced by TNF alpha and by PMA but were inhibited by amiloride at concentrations of 0.1 to 1 mM in the presence or absence of TNF alpha and PMA. Nuclear run-on transcription assay indicated that the effects of amiloride and TNF alpha were mediated at least in part at the transcriptional level, whereas PMA may act in part via a posttranscriptional mechanism. These results suggested that uPAR gene expression is modulated by multiple signal transduction pathways.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7926038     DOI: 10.1016/0014-5793(94)01032-3

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  11 in total

1.  Regulation of urokinase receptor mRNA stability by hnRNP C in lung epithelial cells.

Authors:  Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2005-04       Impact factor: 3.396

2.  Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells.

Authors:  Torry A Tucker; LaTerrica Williams; Kathleen Koenig; Hema Kothari; Andrey A Komissarov; Galina Florova; Andrew P Mazar; Timothy C Allen; Khalil Bdeir; L Vijaya Mohan Rao; Steven Idell
Journal:  Am J Respir Cell Mol Biol       Date:  2012-02       Impact factor: 6.914

Review 3.  Physiology and pathophysiology of the plasminogen system in the kidney.

Authors:  Per Svenningsen; Gitte Rye Hinrichs; Rikke Zachar; Rikke Ydegaard; Boye L Jensen
Journal:  Pflugers Arch       Date:  2017-06-27       Impact factor: 3.657

4.  Upregulation of monocyte urokinase plasminogen activator receptor during human endotoxemia.

Authors:  P E Dekkers; T ten Hove; A A te Velde; S J van Deventer; T van Der Poll
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

5.  Amiloride modulates urokinase gene expression at both transcription and post-transcription levels in human colon cancer cells.

Authors:  Y Wang; J Dang; X Liang; W F Doe
Journal:  Clin Exp Metastasis       Date:  1995-05       Impact factor: 5.150

6.  Urokinase receptor expression involves tyrosine phosphorylation of phosphoglycerate kinase.

Authors:  Praveenkumar Shetty; Thirunavukkarasu Velusamy; Yashodhar P Bhandary; Ming C Liu; Sreerama Shetty
Journal:  Mol Cell Biochem       Date:  2009-09-26       Impact factor: 3.396

7.  A urokinase-derived peptide (A6) increases survival of mice bearing orthotopically grown prostate cancer and reduces lymph node metastasis.

Authors:  Douglas D Boyd; Sun-Jin Kim; Heng Wang; Terence R Jones; Gary E Gallick
Journal:  Am J Pathol       Date:  2003-02       Impact factor: 4.307

8.  A highly polymorphic CA/GT repeat in intron 3 of the human urokinase receptor gene (PLAUR).

Authors:  M R Kohonen-Corish; Y Wang; W F Doe
Journal:  Hum Genet       Date:  1996-01       Impact factor: 4.132

9.  Hexamethylene amiloride engages a novel reactive oxygen species- and lysosome-dependent programmed necrotic mechanism to selectively target breast cancer cells.

Authors:  Ashley R Rowson-Hodel; Anastasia L Berg; Jessica H Wald; Jason Hatakeyama; Kacey VanderVorst; Daniel A Curiel; Leonardo J Leon; Colleen Sweeney; Kermit L Carraway
Journal:  Cancer Lett       Date:  2016-03-02       Impact factor: 8.679

10.  Effect of a synthetic inhibitor of urokinase plasminogen activator on the migration and invasion of human cervical cancer cells in vitro.

Authors:  Xuechun Wang; Zhongqing Jiang; Jian An; Xiaodan Mao; Fen Lin; Pengming Sun
Journal:  Mol Med Rep       Date:  2018-01-09       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.